🇺🇸 FDA
Patent

US 9221792

N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators

granted A61KA61K31/4709A61P

Quick answer

US patent 9221792 (N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators) held by Agios Pharmaceuticals, Inc. expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4709, A61P, A61P35/00, A61P43/00